Skip to main content
. 2016 Dec;8(12):3682–3690. doi: 10.21037/jtd.2016.12.22

Figure 3.

Figure 3

LMO4 levels are significantly associated with patient overall survival (OS) in different tumor stages and sizes. (A,B) OS of patients with high or low-LMO4 expression when further divided into tumor-node-metastasis (TNM) I–II and TNM III–IV subgroups; (C,D) OS rates of patients with tumor size ﹤3 cm and tumor size ≥3 cm, respectively.